Physician-pharmacist collaboration on chronic non-cancer pain management during the opioid crisis: A qualitative interview study

Healthcare provider knowledge, beliefs, and attitudes regarding opioids for chronic non-cancer pain in North America prior to the emergence of COVID-19: A systematic review of qualitative research

“… Low confidence Serious concerns about methodological limitations, adequacy, and relevance. Moderate concerns about coherence Theme 9: Use of PDMPs for risk management contributed to providers’ confidence in opioid prescribing and discontinuation 33 , 35 , 36 , 39 , 40 , 47 , 49 , 50 , 52 , 54 , 55 , 58 The use of PDMP, UDTs, and patient history were perceived as beneficial to decision making for opioid prescribing, better management of medications, and the prevention of opioid abuse and diversion Moderate confidence Moderate concerns about methodological limitations and coherence Mixed Theme 10: External policies and tools increased providers’ confidence in decisions to prescribe or discontinue opioids. Meanwhile, external pressures decreased willingness to prescribe 10.1 Providers adopted a defensive stance when prescribing opioids 33 , 34 , 40 , 41 , 43 , 44 , 46 , 47 , 52 Most providers adopt a position of distrust, or a “defensive stance,” when entering a patient–provider relationship and prescribing opioids.…”

A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder

“… 51 The main focus is on the need and opportunities for collaboration between physician and community pharmacists to manage chronic non-cancer pain in the context of the opioid epidemic. 52 This study discusses the healthcare system's weaknesses that healthcare professionals have to mitigate opioid abuse and diversion. 52 One of the most critical weaknesses discussed by physicians is the need for additional supports and resources for chronic pain management.…”

“… 52 This study discusses the healthcare system's weaknesses that healthcare professionals have to mitigate opioid abuse and diversion. 52 One of the most critical weaknesses discussed by physicians is the need for additional supports and resources for chronic pain management. At the same time, pharmacists identified cost as the major obstacle to initiate new services.…”

Popcorn in the pain clinic: A content analysis of the depiction of patients with chronic pain and their management in motion pictures

“…Pharmacists are also known to play an important role as part of the multidisciplinary team that helps with chronic pain management, and interactions that patients have with their pharmacists influence the quality of their care. 91–94 This has been especially clear during the COVID-19 pandemic in which limitations to patients’ abilities to physically attend pain clinics meant that pharmacists played a larger role in monitoring for opioid aberrant behaviors and liaising with physicians about potential concerns about opioid misuse. 95 , 96 Pharmacists were rarely depicted in the films reviewed, however.…”